The National Agency for Food and Drug Administration and Control (NAFDAC), on Thursday, approved the use of AstraZeneca Vaccine for use in Nigeria.
The NAFDAC Director-General, Prof. Mojisola Adeyeye, made the disclosure in Abuja on Thursday.
With the latest development, the country stands in a better position in the ongoing battle against the infection of COVID-19 pandemic among the global community.
It would be recalled that the Astrazeneca vaccine was recently approved by the World Health Organization for emergency use to curtail the spread of COVID-19
The NAFDAC DG at a press conference in Abuja disclosed that the agency got the dossier of the vaccine a week ago, while its safety committee went to work immediately to evaluate its safety and efficacy for Nigerians.
While affirming that the vaccine could be stored in two to eight degrees Centigrade, she explained that there were three additional vaccines undergoing evaluation.
Adeyeye added that the evaluation on Astrazeneca shows that the vaccine is effective against the United Kingdom variant of the virus which has been reported in Nigeria.
She stressed that the South African variant has not been reported in Nigeria, while the agency has over 30 herbal medicines undergoing review for listing.